Small interfering RNA-induced suppression of ERCC1 enhances sensitivity of human cancer cells to cisplatin
- 1 February 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 327 (1), 225-233
- https://doi.org/10.1016/j.bbrc.2004.12.008
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- DNA repair and cisplatin resistance in non-small-cell lung cancerLung Cancer, 2002
- Nucleotide excision repair and human syndromesCarcinogenesis: Integrative Cancer Research, 2000
- Damage recognition in nucleotide excision repair of DNAGene, 1999
- Single d(GpG)/cis-Diammineplatinum(II) Adduct-Induced Inhibition of DNA PolymerizationBiochemistry, 1998
- Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapyCancer Treatment Reviews, 1998
- Cisplatin and DNA repair in cancer chemotherapyTrends in Biochemical Sciences, 1995
- Excision Repair in Mammalian CellsJournal of Biological Chemistry, 1995
- The General Transcription-Repair Factor TFIIH Is Recruited to the Excision Repair Complex by the XPA Protein Independent of the TFIIE Transcription FactorJournal of Biological Chemistry, 1995
- An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts.Proceedings of the National Academy of Sciences, 1992
- Molecular characterization of the human excision repair gene : cDNA cloning and amino acid homology with the yeast DNA repair geneCell, 1986